Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
This research is Trending!
September 16, 2026European Heart JournalOpen Access

Whole-grain consumption and cardiometabolic risk: a meta-analysis of randomized trials

View Full Paper
Ask AI
Bookmark
Share

Key result

Higher whole-grain intake is linked to ~0.2 kg weight loss and reduced cardiometabolic risk.

  • MD -0.20 kg
  • 95% CI -0.31 to -0.09

Why the study?

Higher whole-grain intake is associated with lower cardiometabolic disease risks, but the underlying mechanisms remain unclear.

Does whole-grain intake improve cardiometabolic risk factors?

Comparison

Whole-grain intake increments vs lower or no whole-grain intake

Design

Random-effects meta-analysis of randomized trials

Authors

SNSina NaghshiTabriz University of Medical SciencesSKSevil KianiTabriz University of Medical SciencesAOAlireza OstadrahimiTabriz University of Medical Sciences

Discussion

Loading...

Member takes

Key expert perspectives

Captured external expert commentary on this paper, strongest first. Original sources are linked where available.

HTHelda TutunchiNutrition researcher, Tabriz University of Medical Sciences

“One important finding is that whole grains may benefit cardiovascular health through several modest improvements acting together, rather than through one large effect on a single risk factor. We observed improvements across multiple pathways, including blood lipids, blood pressure, glucose regulation, body fat and some markers of inflammation. Although the change in each individual risk factor was generally modest, improving several risk factors simultaneously could contribute to a greater reduction in long-term cardiovascular risk. However, the included trials did not assess cardiovascular events directly, so longer-term studies are needed to confirm this.”

Tabriz University of Medical SciencesNews Coverage
CKCecilie KyrøSenior scientist, Danish Cancer Institute, Copenhagen

“For clinicians, the message from Naghshi et al. is reassuringly simple: encouraging patients to replace refined grain foods with minimally processed whole grains is likely to yield modest but meaningful improvements in body weight, waist circumference, and blood lipids, perhaps particularly in individuals with type 2 diabetes. At the population level, even small shifts in these markers can translate into substantial reductions in cardiometabolic events. Adding evidence from research into other disease endpoints indicates that the beneficial effects of whole-grains foods even go substantially beyond cardiometabolic disease.”

Danish Cancer InstituteEditorial
CCCheng-Han ChenInterventional cardiologist, MemorialCare Saddleback Medical Center

“Making whole grains a regular part of your diet is a simple dietary change that can support long-term heart health. Even small, consistent choices, such as choosing whole-grain bread or brown rice instead of refined versions, can add up over time.”

MemorialCare Saddleback Medical CenterNews Coverage

Implication

Supports advising 60–100 g/day whole grains to modestly improve cardiometabolic risk; extends observational associations with RCT meta-analysis evidence.

Key Points

  • To assess the effects of whole-grain intake on cardiometabolic risk factors and characterize dose-response relationships.
  • Included 87 randomized trials across 101 publications evaluating whole-grain consumption against cardiometabolic endpoints.
  • Conducted random-effects meta-analyses to estimate mean differences (MDs) with 95% confidence intervals per 48 g/day dry weight increment (~90 g fresh weight), alongside non-linear dose-response analyses.
  • Each 48 g/day whole-grain increase was associated with reductions in body weight (MD: -0.20 kg; 95% CI: -0.31 to -0.09), waist circumference (MD: -0.22 cm; 95% CI: -0.39 to -0.06), total cholesterol (MD: -0.10 mmol/L; 95% CI: -0.13 to -0.07), and interleukin-6 (MD: -0.12 pg/mL; 95% CI: -0.23 to -0.00) with high certainty.
  • Intake also reduced low-density lipoprotein cholesterol (MD: -0.07 mmol/L; 95% CI: -0.10 to -0.05), triglycerides (MD: -0.04 mmol/L; 95% CI: -0.06 to -0.02), fasting plasma glucose (MD: -0.03 mmol/L; 95% CI: -0.06 to -0.00), and systolic blood pressure (MD: -0.82 mmHg; 95% CI: -1.49 to -0.15) with moderate certainty.
  • Non-linear dose-response analyses indicated that the greatest risk reductions occurred at 60–100 g/day for most outcomes, with higher intakes up to 180–220 g/day benefiting select markers.

Study Design

Type

Meta-Analysis

Structured PICO

Does whole-grain intake improve cardiometabolic risk factors?

P
Population
Meta-analysis of 87 randomized trials evaluating the effects of whole grains on cardiometabolic risk factors.
I
Intervention
Whole-grain intake (evaluated per 48 g/day increment of dry weight, equivalent to ~90 g or 3 servings of fresh weight)
O
Outcome
Cardiometabolic risk factors including body weight, waist circumference, total cholesterol, interleukin-6, low-density lipoprotein cholesterol, triglycerides, fasting plasma glucose, and systolic blood pressuresurrogate

Main Result

Mean Difference: -0.2 (95% CI -0.31–-0.09)

Higher whole-grain intake, particularly at 60-100 g/day, is associated with modest but significant improvements in multiple cardiometabolic risk factors.

Limitations

  • sparse data at higher intake levels limit firm conclusions regarding dose thresholds
  • Sparse data at higher intake levels limit firm conclusions regarding dose thresholds

Coverage & sources

Journal, society, and media accounts. Useful signal, not independent expert judgment.

Cite This Study

Naghshi et al. (2026) conducted a meta-analysis in cardiometabolic risk factors. Whole-grain consumption was evaluated on body weight (MD -0.20 kg, 95% CI -0.31 to -0.09). Each 48 g/day increment in whole-grain intake was associated with reductions in body weight (MD -0.20 kg; 95% CI -0.31 to -0.09), waist circumference, total cholesterol, and interleukin-6.

synapsesocial.com/papers/6aab07331655d1e52954cbfchttps://doi.org/10.1093/eurheartj/ehag519
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Whole Grain Products, Fish and Bilberries Alter Glucose and Lipid Metabolism in a Randomized, Controlled Trial: The Sysdimet Study2011 · 103 citations
  2. 2Major Lipids, Apolipoproteins, and Risk of Vascular Disease2009 · 2,804 citations
  3. 3Effects of whole grain intake on glycemic control: A meta‐analysis of randomized controlled trials2022 · 17 citations